The most prominent health care companies ranked by global prominence, funding activity, and market position. Showing the top 50 out of 268,928 companies tracked on Fsome.
| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer a…
|
Cambridge | 101 - 250 | $624.3M | Series E | 2025-03-13 |
| 2 |
Function Health
Function Health is a health platform offering lab tests to help individuals moni…
|
Austin | — | $354.0M | Series B | 2025-11-19 |
| 3 |
Oura
Oura designs and develops wearable rings that track sleep and performance metric…
|
Oulu | — | $1.5B | Series E | 2025-10-14 |
| 4 |
Hippocratic AI
Hippocratic AI is a healthcare technology company that develops safety-focused l…
|
Palo Alto | — | $402.0M | Series C | 2025-11-03 |
| 5 |
Phinge
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed…
|
Incline Village | 1 - 10 | $2.1M | Convertible Note | 2026-04-17 |
| 6 |
Chai Discovery
Chai Discovery develops artificial intelligence models that predict and reprogra…
|
San Francisco | — | $231.0M | Series B | 2025-12-15 |
| 7 |
Honor
Honor Technology provides aging care solutions and home care services.
|
Concord | 501 - 1K | $625.0M | Debt Financing | 2021-10-05 |
| 8 |
Orca Bio
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curati…
|
Menlo Park | 251 - 500 | $542.0M | Series F | 2026-01-09 |
| 9 |
Spring Health
Spring Health provides mental health solution for employers and health plans.
|
New York | 1K - 5K | $466.5M | Series E | 2024-07-31 |
| 10 |
Juvena Therapeutics
Juvena Therapeutics develops tissue-restorative biologics to address chronic mus…
|
Palo Alto | 11 - 50 | $113.2M | Series B | 2026-01-12 |
| 11 |
Parabilis Medicines
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specialize…
|
Cambridge | 101 - 250 | $835.3M | Series F | 2026-01-08 |
| 12 |
Alumis
Alumis is a precision medicine company focused on the discovery, development and…
|
San Francisco | 101 - 250 | $917.2M | Post Ipo Equity | 2026-01-07 |
| 13 |
Mediar Therapeutics
Mediar is a pre-clinical stage biotechnology company developing therapeutics for…
|
Cambridge | 11 - 50 | $181.0M | Series B | 2026-01-07 |
| 14 |
Tempus
Tempus develops AI-enabled precision medicine technology that supports clinical …
|
Chicago | 1K - 5K | $2.3B | Post Ipo Debt | 2025-06-30 |
| 15 |
Commure
Commure is an AI-based company that specializes in health care.
|
Mountain View | 251 - 500 | $820.5M | Series E | 2025-06-19 |
| 16 |
Vivo
Vivo offers an online and interactive fitness program designed specifically for …
|
Atlanta | 1 - 10 | $1.1M | Seed | 2021-11-08 |
| 17 |
Tebra
Tebra provide independent healthcare practices with digital tools and support to…
|
Corona Del Mar | 501 - 1K | $387.0M | Series Unknown | 2025-12-17 |
| 18 |
Rakuten Medical
Rakuten Medical is a biotechnology company developing investigational cancer the…
|
San Diego | 101 - 250 | $837.6M | Corporate Round | 2026-04-02 |
| 19 |
Ceribell
Ceribell focuses on making electroencephalography accessible, efficient, and cos…
|
Mountain View | 251 - 500 | $171.0M | Series C | 2022-09-21 |
| 20 |
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, an…
|
Paris | c 10001 max | $7.0B | Post Ipo Debt | 2025-10-28 |
| 21 |
Withings
Withings is a developer of digital health and wellness smart devices such as fit…
|
Issy-les-moulineaux | 251 - 500 | $115.6M | Grant | 2024-12-04 |
| 22 |
Truemed
Truemed operates an HSA and FSA marketplace enabling eligible individuals to pur…
|
Austin | 11 - 50 | $37.5M | Series A | 2025-12-22 |
| 23 |
Alamar Biosciences
Alamar Biosciences develops technologies for the detection and treatment of canc…
|
Fremont | 51 - 100 | $282.0M | Convertible Note | 2026-01-11 |
| 24 |
Aidoc
Aidoc develops artificial intelligence tools for radiologists and multidisciplin…
|
Tel Aviv | 251 - 500 | $414.0M | Series Unknown | 2025-07-23 |
| 25 |
Brightline
Brightline is a med-tech company that provides behavioral healthcare services fo…
|
Palo Alto | 251 - 500 | $212.0M | Series C | 2022-07-12 |
| 26 |
Talkspace
Talkspace is a digital therapy company that offers online therapy, online counse…
|
New York | 501 - 1K | $413.7M | Post Ipo Equity | 2021-06-23 |
| 27 |
BrightInsight
BrightInsight offers a global regulated digital health platform for biopharma an…
|
Sunnyvale | 101 - 250 | $179.0M | Series Unknown | 2026-01-20 |
| 28 |
Eternal
Eternal is here to redefine what healthcare looks and feels like for those who c…
|
San Francisco | 11 - 50 | $13.0M | Seed | 2025-02-08 |
| 29 |
Aktis Oncology
Aktis Oncology is a biotechnology company that designs and develops novel class …
|
Boston | 51 - 100 | $331.0M | Series B | 2024-09-30 |
| 30 |
VieCure
VieCure built an engine to turn data into knowledge and take the world’s best th…
|
Denver | 51 - 100 | $113.0M | Series Unknown | 2026-01-12 |
| 31 |
Doctronic
Doctronic is the #1 AI doctor delivering secure, accurate, and instant medical g…
|
New York | 51 - 100 | $65.0M | Series B | 2026-03-23 |
| 32 |
Freenome
Freenome is a biotechnology company developing blood tests for early cancer dete…
|
South San Francisco | 251 - 500 | $1.5B | Corporate Round | 2025-11-17 |
| 33 |
Exciva
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing…
|
Heidelberg | 1 - 10 | $69.8M | Series B | 2026-01-20 |
| 34 |
Metsera
Metsera is a clinical-stage biotech firm developing oral & injectable hormone th…
|
New York | 51 - 100 | $505.0M | Series B | 2024-11-13 |
| 35 |
Pee Safe
Started in 2013, Redcliffe Hygiene Private Limited is India's fastest growing hy…
|
Gurgaon | 101 - 250 | $44.7M | Secondary Market | 2026-01-14 |
| 36 |
Vivoo
Vivoo is an at-home health tracker that uses urine to provide personalized recom…
|
San Francisco | 51 - 100 | $22.1M | Series B | 2024-07-15 |
| 37 |
LifeMD
LifeMD is a comprehensive telehealth platform that offers virtual primary care a…
|
New York | 251 - 500 | $50.0M | Post Ipo Debt | 2026-01-06 |
| 38 |
Century Therapeutics
Century Therapeutics is a biotechnology company that develops cell therapies for…
|
Philadelphia | 101 - 250 | $755.0M | Post Ipo Equity | 2026-01-08 |
| 39 |
Ukko
Ukko is a biotechnology company focused on developing immunotherapies for the tr…
|
Palo Alto | 11 - 50 | $92.7M | Series C | 2026-01-08 |
| 40 |
Clue
Clue is a female health application for period and fertility tracking
|
Berlin | 51 - 100 | $73.7M | Private Equity | 2026-01-15 |
| 41 |
Caris Life Sciences
Caris Life Sciences develops molecular profiling and AI-driven technologies to s…
|
Irving | 1K - 5K | $1.9B | Private Equity | 2025-04-07 |
| 42 |
Teal Health
Teal Health is a health tech company that develops cervical cancer screening and…
|
San Francisco | 11 - 50 | $21.5M | Seed | 2025-01-16 |
| 43 |
Femasys
Femasys engages in R&D and manufacture of medical devices for women's healthcare…
|
Suwanee | 11 - 50 | $95.3M | Post Ipo Debt | 2025-11-03 |
| 44 |
Galderma
Galderma offering a range of medical and consumer skin health solutions through …
|
Lausanne | 5K - 10K | $9.3B | Post Ipo Secondary | 2025-12-08 |
| 45 |
Kinaset Therapeutics
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel…
|
Boston | 1 - 10 | $144.5M | Series B | 2026-01-10 |
| 46 |
ProsperOps
ProsperOps is an autonomous cloud platform that optimizes AWS savings.
|
Austin | 51 - 100 | $72.0M | Series A | 2023-02-23 |
| 47 |
Precede Biosciences
Precede Biosciences is a biotechnology company that provides a blood-based appro…
|
Boston | 11 - 50 | $140.5M | Series B | 2026-01-12 |
| 48 |
b.well Connected Health
B.well Connected Health is a digital health platform that provides individuals w…
|
Baltimore | 101 - 250 | $118.8M | Debt Financing | 2025-07-30 |
| 49 |
Rocket Doctor AI
Rocket Doctor AI offers AI-powered healthcare software and services that support…
|
Vancouver | 101 - 250 | $19.9M | Post Ipo Equity | 2026-01-09 |
| 50 |
Elation Health
Elation Health is a technology platform designed for independent primary care, d…
|
San Francisco | 101 - 250 | $108.5M | Series D | 2022-07-26 |